Home › NCT07688304
The Abuse Liability of IQOS Heated Tobacco Products Among Adults Who Smoke
RecruitingHealthy volunteers welcome
Studying User Sensory Experiences and Smoking Behavior of IQOS Heated Tobacco Products to Improve Harm Reduction Among Adult Cigarette Smokers
Who can join
Ages 21 to 65 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Adults 21-65 years * Adults who smoke (defined as ≥ 5 days weekly use of either menthol or non-menthol cigarettes over the past 3 months) * Willing to provide informed consent and abstain from using nicotine products 12 hours before each visit * Willing to bring UBC to each study visit * Read, write and speak English Exclusion Criteria: * Current use of other non-combustible nicotine products (e.g., electronic \[e\]-cigarettes, HTPs; \[defined as ≥ 5 days weekly use in the past 30 days\]) * Planning to quit nicotine use and/or use of any smoking cessation medication in the past 30 days * Current diagnosis of any lung diseases (e.g., asthma, cystic fibrosis, or chronic obstructive pulmonary disease) * Self-reported unstable or significant psychiatric conditions (past/stable conditions will be allowed) * History of cardiac event or distress within the past 3 months * Deaf, hard of hearing, or have a severe motor disability * Are currently pregnant, planning to become pregnant, or breastfeeding (urine pregnancy test will be completed at each visit throughout the study)
About the study
This clinical trial aims to evaluate user sensory experiences and smoking behavior when using IQOS heated tobacco products (HTPs) among adults who smoke cigarettes.
What is being tested
- Smoking Behavioral Research (IQOS) (behavioral)
- Smoking Behavioral Research (UBC) (behavioral)
Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 30 · Started: Aug 27, 2026
Contact the study team
- The Ohio State University Comprehensive Cancer Center · Phone: 800-293-5066
Official record on ClinicalTrials.gov — NCT07688304
Locations in the U.S.
| Ohio | Ohio State University Comprehensive Cancer Center, Columbus |
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.